Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
Conditions: Ductal Carcinoma in Situ; Extensive Disease; Mastectomy Interventions: Drug: Tamoxifen 20 mg; Drug: Anastrozole 1Mg Tab Sponsor: Institut Cancerologie de l'Ouest Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Hormonal Therapy | Hormones | Mastectomy | Neoadjuvant Therapy | Research